UBS Maintains a 'Buy' on Genesis Energy LP (GEL); Supply & Logistics Drives 3Q11 Results
Get Alerts GEL Hot Sheet
Price: $15.83 +0.06%
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
UBS maintains a 'Buy' on Genesis Energy LP (NYSE: GEL) price target raised $1 to $28.
UBS analyst says, "Supply & Logistics’ $18.9 MM segment margin was up 68% YOY and contributed 57% of Genesis’s $13.6 MM increase in segment profit (although this was aided by ~$2.9 MM from the Florida Marine acquisition, closed Aug 2011). Pipeline transportation profit also increased 34%, driven by YOY volume increases, esp on GEL’s Texas Pipeline System. In addition, the return of Mad Dog in late Nov should aid CHOPS vols and GEL cash flow."
UBS bumps FY11-12 EPS estimate to $1.09 and $1.41 from $1.07 and $1.37, respectively.
For an analyst ratings summary and ratings history on Genesis Energy LP click here. For more ratings news on Genesis Energy LP click here.
Shares of Genesis Energy LP closed at $25.96 yesterday.
UBS analyst says, "Supply & Logistics’ $18.9 MM segment margin was up 68% YOY and contributed 57% of Genesis’s $13.6 MM increase in segment profit (although this was aided by ~$2.9 MM from the Florida Marine acquisition, closed Aug 2011). Pipeline transportation profit also increased 34%, driven by YOY volume increases, esp on GEL’s Texas Pipeline System. In addition, the return of Mad Dog in late Nov should aid CHOPS vols and GEL cash flow."
UBS bumps FY11-12 EPS estimate to $1.09 and $1.41 from $1.07 and $1.37, respectively.
For an analyst ratings summary and ratings history on Genesis Energy LP click here. For more ratings news on Genesis Energy LP click here.
Shares of Genesis Energy LP closed at $25.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
- Benchmark Reiterates Hold Rating on VolitionRX (VNRX)
- UBS Reiterates Buy Rating on Block Inc. (XYZ)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share